• Applied Workflows with Resiniferatoxin (RTX) for TRPV1 Resea

  2026-06-15

  Resiniferatoxin (RTX) delivers ultra-potent, long-lasting TRPV1 activation, enabling advanced pain modeling and sensory neuron desensitization. This guide translates recent discoveries—like cholesterol's key role in TRPV1 function—into actionable protocols, troubleshooting, and comparative insights for researchers seeking reproducible, high-impact results.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Guide

  2026-06-15

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat IgG targets in fluorescence-based immunoassays, facilitating signal amplification with minimal background. It is best suited for ICC/IF, IHC (frozen and paraffin), flow cytometry, and ELISA workflows requiring robust fluorescent secondary antibody performance. This antibody should not be used for detection of non-goat immunoglobulins or outside fluorescence-based assay modalities.

• Machine Learning Predicts Ionizable Lipids for mRNA Vaccine

  2026-06-14

  This study pioneers a machine learning-based approach to predict optimal lipid nanoparticle (LNP) formulations for mRNA vaccine delivery, focusing on ionizable cationic liposomes like Dlin-MC3-DMA. By integrating experimental validation and molecular modeling, the work establishes a robust framework for accelerating nucleic acid therapeutic development.

• ICOS Signaling Drives Th2 Differentiation in Allergic Rhinit

  2026-06-13

  The reference study uncovers how inducible co-stimulator (ICOS) signaling regulates the differentiation of T-cell subsets, particularly Th2 cells, contributing to the pathogenesis of allergic rhinitis. These insights highlight ICOS-expressing Th2 cells as a promising therapeutic target and provide mechanistic context for immunomodulatory strategies.

• WNT5a/GSK3/β-catenin Axis Controls FAP Adipogenesis in Muscl

  2026-06-12

  This study uncovers the WNT5a/GSK3/β-catenin signaling axis as a critical regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). The findings provide mechanistic insight into how modulating this pathway can influence muscle regeneration and counteract fatty degeneration, with implications for translational research in myopathies and muscle biology.

• NF 340: A Selective P2Y11 Antagonist Transforming GPCR Resea

  2026-06-12

  NF 340 empowers researchers to precisely interrogate P2Y11-driven GPCR signaling—vital for dissecting immune modulation, inflammation, and cancer cell invasiveness. Its robust selectivity, as highlighted in recent mechanistic studies, streamlines protocol optimization and troubleshooting for reliable experimental outcomes.

• Acacetin–MAPK1/HMOX1 Axis Regulates Pyroptosis in IVDD Thera

  2026-06-11

  This study identifies a novel mechanism by which Duhuo Jisheng decoction (DHJS) and its active component acacetin alleviate intervertebral disc degeneration (IVDD) through the MAPK1/HMOX1 axis, inhibiting nucleus pulposus cell pyroptosis and enhancing mitophagy. These findings provide foundational insight into mitophagy–pyroptosis crosstalk as a therapeutic target for degenerative disc disease.

• Tin Mesoporphyrin IX: Applied Strategies for Heme Oxygenase

  2026-06-11

  Tin Mesoporphyrin IX (chloride) is redefining metabolic and virological research workflows with unparalleled potency and selectivity as a heme oxygenase inhibitor. This article details stepwise protocols, advanced troubleshooting, and the translational impact of leveraging APExBIO’s rigorously benchmarked compound in both metabolic and viral disease models.

• Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce

  2026-06-10

  Wei et al. (2019) reveal that Spiroplasma eriocheiris invades Drosophila Schneider 2 cells via clathrin-mediated endocytosis and macropinocytosis, with infection critically dependent on intact microtubule and actin cytoskeletons. These findings deepen the understanding of host-pathogen interactions in invertebrate models and open avenues for dissecting cytoskeletal contributions to infection processes.

• DeferoxamineB: Precision Iron Modulation for Regulated Cell

  2026-06-10

  This article explores how Deferoxamine (DeferoxamineB) enables translational researchers to leverage iron chelation for the strategic modulation of ferroptosis and cuproptosis in cancer research. Integrating mechanistic insights, state-of-the-art protocol guidance, and the latest evidence on metabolic interventions, this thought-leadership piece elevates the conversation beyond routine product pages—offering actionable strategies for scientists pursuing next-generation regulated cell death therapies.

• Transcription Termination Limits DNA Damage After WEE1 Inhib

  2026-06-09

  This study demonstrates that efficient transcription termination is critical for preventing DNA damage following WEE1 kinase inhibition, highlighting a new regulatory layer in genome integrity maintenance. The findings have significant implications for designing combinatorial cancer therapies targeting transcription-replication conflicts.

• siRNA Nanoparticles Target TDRD9 to Mitigate P. aeruginosa L

  2026-06-09

  This study introduces a hyaluronic acid sodium salt-coated siRNA nanoparticle platform targeting TDRD9 in neutrophils, uncovering a mechanism of enhanced cuproptosis that reduces Pseudomonas aeruginosa-induced lung injury. The findings provide a new direction for immune modulation therapies in bacterial pneumonia.

• SlSLAH1-Mediated Malate Exudation Pathway in Tomato Aluminum

  2026-06-08

  This study identifies the SlSLAH1 anion channel as a key plasma membrane malate transporter regulated by the transcription factor SlSTOP1, conferring aluminum (Al) tolerance in tomato. By defining a novel regulatory module involving SlSLAH1, SlSLAH2, and SlSTOP1/SlSZP1, the work advances mechanistic understanding of Al detoxification and offers new targets for engineering aluminum-tolerant crops.

• Cy7 NHS Ester: Protocol Guide for Near-Infrared Protein Labe

  2026-06-08

  Cy7 NHS ester is a sulfonated, water-soluble near-infrared dye that enables efficient, low-quenching labeling of proteins and peptides for live cell and tissue imaging applications. It solves common issues with hydrophobic dye aggregation and is ideal for protocols requiring high sensitivity and compatibility with delicate biomolecules. However, its use is not recommended for long-term storage of labeled conjugates or for non-amino group labeling workflows.

• Connexin 43 and EAATs in Breakthrough Cancer Pain: Insights

  2026-06-07

  This study introduces a rigorously validated mouse model of breakthrough cancer pain (BTcP) and delineates a mechanistic link between spinal astrocytic EAAT downregulation, enhanced connexin 43 phosphorylation, and pain hypersensitivity. The findings highlight the therapeutic potential of targeting astrocytic gap junctions and excitatory amino acid transporters for BTcP intervention.

15018 records 1/1002 page Next 12345 下5页 Last page